Search Login Register

Gray Platelet Syndrome Summary

Description: A rare, inherited platelet disorder characterized by a selective deficiency in the number and contents of platelet alpha-granules. It is associated with THROMBOCYTOPENIA, enlarged platelets, and prolonged bleeding time.

Also Known As: Grey Platelet Syndrome; Platelet alpha-Granule Deficiency; Gray Platelet Syndromes; Grey Platelet Syndromes; Platelet Syndromes, Grey Show All >>

Networked: 69 relevant articles (2 outcomes, 5 trials/studies) for this Disease

Key Drugs and Agents for Gray Platelet Syndrome

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Proteins (Proteins, Gene) : 2 outcomes 1 study in 17 results : IBA
  2. Thrombin : 1 study in 8 results : FDA 2
  3. May-Hegglin anomaly : 1 study in 6 results : IBA
  4. Factor V (Coagulation Factor V) : 1 study in 3 results : IBA
  5. Tubulin : 1 study in 1 result : IBA
  6. Peroxidase (Myeloperoxidase) : 1 study in 1 result : IBA
  7. P-Selectin : 4 results : IBA
  8. Glycoproteins (Glycoprotein) : 4 results : IBA
  9. Antibodies : 4 results : IBA
  10. von Willebrand Factor : 3 results : IBA
Show All >>

Diseases Related to Gray Platelet Syndrome

  1. Platelet Storage Pool Deficiency
  2. Hemorrhage
  3. Thrombasthenia (Glanzmann Thrombasthenia)
  4. Thrombocytopenia (Thrombopenia)
  5. Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
Show All >>

Key Therapies for Gray Platelet Syndrome

Efficacy Chart >>
  1. Hematopoietic Stem Cell Transplantation : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.